Skip to main content
All lobbying filings

The Petrizzo Group, Inc.

The Petrizzo Group, Inc. filed a Q2 report for Akebia Therapeutics, Inc. on July 11, 2025, reporting $45,000 in lobbying income.

Lobbying for Akebia Therapeutics, Inc. · Fully integrated biopharmaceutical company addressing complications of kidney disease.

As filed: THE PETRIZZO GROUP, INC. for AKEBIA THERAPEUTICS, INC.

All filings by The Petrizzo Group, Inc. · Everything Akebia Therapeutics, Inc. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 11, 2025
Income
$45,000
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Lobbyists on this filing 1
  • MEGAN CRISTINA PEREZ BURKE
    Previously held: Health Policy Advisor, and Legislative Director to Chair McMorris Rodgers

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Health Issues

Provided legislative advocacy specific to the payment of innovative drugs, such as phosphate binders and anemia management drugs in the Medicare End-Stage Renal Dialysis Prospective Payment System (ESRD PPS).

Medicare/Medicaid

Provided legislative advocacy specific to the payment of innovative drugs, such as phosphate binders and anemia management drugs in the Medicare End-Stage Renal Dialysis Prospective Payment System (ESRD PPS).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem